Target intelligence / Profile preview

Cytochrome bc1 complex cytochrome b Qi site (Cytochrome bc1 Qi site)

Target
Cytochrome bc1 Qi site
Molecular classification
Enzyme, Oxidoreductase, Mitochondrial respiratory chain complex, Membrane protein
01

Overview

The cytochrome bc1 complex (Complex III) is a multi-subunit enzyme essential for cellular respiration in fungi and many bacteria (UniProt P00123). It functions within the electron transport chain to catalyze the oxidation of ubiquinol and the reduction of cytochrome c, a process coupled with the translocation of protons across the membrane to generate a proton motive force (PMID: 10548711). The Qi site, located on the cytochrome b subunit, is the internal catalytic site where ubiquinone is reduced back to ubiquinol during the Q-cycle (Wikipedia: Cytochrome bc1 complex). This site is a validated therapeutic target for various antimicrobial and antifungal agents, including agricultural fungicides like cyazofamid and the classic laboratory inhibitor antimycin A (PubChem CID 16219144). By binding to the Qi site, these drugs block electron flow and ATP synthesis, leading to metabolic arrest and cell death (PMID: 29654105). Research focuses on exploiting structural differences between microbial and human Qi sites to achieve selective toxicity and minimize host side effects (PMID: 25613125).

Other names
Complex III Qi siteUbiquinone reduction siteQi pocketCytochrome b Qi siteUbiquinol-cytochrome c reductase Qi site
02

Mechanism of action

Inhibition of the Qi site blocks the reduction of ubiquinone to ubiquinol within the Q-cycle of the cytochrome bc1 complex (PMID: 10548711). This disruption halts the electron transport chain, prevents the generation of a proton gradient across the membrane, and ultimately inhibits ATP synthesis, leading to microbial cell death (PMID: 29654105).

03

Biological functions

Electron transportProton motive force generationATP synthesisCellular respiration
04

Disease associations

InfectionBacterial infectionFungal infection
05

Safety considerations

Cross-reactivity with human mitochondrial Complex III (PMID: 25613125)Potential for mitochondrial toxicity in host cellsDevelopment of antimicrobial resistance through mutations in the cytochrome b gene (PMID: 12142478)
06

Interacting drugs

Antimycin A

4 more in the full profile.

07

Biomarkers

Microbial growth inhibitionIntracellular ATP levelsOxygen consumption rate (OCR)Mitochondrial membrane potential

Beyond the preview

Go deeper on Cytochrome bc1 complex cytochrome b Qi site (Cytochrome bc1 Qi site).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytochrome bc1 complex cytochrome b Qi site (Cytochrome bc1 Qi site).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call